跳至主要内容
临床试验/DRKS00011790
DRKS00011790招募中未知

Identification of individual cancer mutations and analysis of their immunogenicity - RB_T002

BioNTech SE0 个研究点目标入组 1,000 人开始时间: 2017年4月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
BioNTech SE
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • signed informed consent; Health condition, that allows planned interventions (according clinical standards);
  • Hemoglobin value = 10,0 g / dl;
  • Patient with suspected/confirmed malign tumor with either already excised/planned excision of tumor material and/or possibility of tumor biopsies exclusively taken for the research project

排除标准

  • Known pregnancy or breastfeeding;
  • Known acute or chronically active hepatitis infection, known HIV infection;
  • Patients who are incapable to give consent or are not able to understand the nature of the project;
  • serious concomitant disease or other circumstances (e.g. psychological, familial, sociological or geographical circumstances), which do not allow an adequate participation

研究者

发起方
BioNTech SE

相似试验